🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 23 of 857 · Phase 3 first, then by program name

  1. Avtozma 20 mg/mL concentrate for solution for infusion., BI 764532, Carboplatin Hikma 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Etoposid Hikma 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung

    Boehringer Ingelheim

    advanced or metastatic extrapulmonary neuroendocrine carcinoma

    phase 3 small molecule active

    1 trial

  2. Axatilimab (INCA034176)

    Incyte

    Chronic Graft-Versus-Host Disease

    phase 3 small molecule active

    1 trial

  3. Azacitidin Zentiva 25 mg/ml Pulver zur Herstellung einer Injektionssuspension, Azacitidine 25 mg/mL powder for suspension for injection, SY-1425, Placebo for Tamibarotene (SY-1425), AZACITIDINE

    Lacuna Pharma Pty Ltd

    Newly Diagnosed RARA-positive Adult Patients with Higher-risk Myelodysplastic Syndrome

    phase 3 small molecule active

    1 trial

  4. Azacitidine

    Takeda

    Myelodysplastic Syndrome

    phase 3 small molecule completed

    1 trial

  5. Azacitidine Combined With Venetoclax and ATRA group

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  6. Azacitidine, Cedazuridine, Azacitidine, Vidaza 25 mg/ml powder for suspension for injection, Azacitidine, Cedazuridine

    Taiho Pharma Netherlands B.V.

    Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML)

    phase 3 small molecule active

    1 trial

  7. Azathioprine

    The First People's Hospital of Lianyungang

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial

  8. Azelastine hydrochloride and Fluticasone propionate

    Teva Pharma GmbH

    Seasonal Allergic Rhinitis

    phase 3 small molecule active

    1 trial

  9. Azeliragon

    vTv Therapeutics

    Alzheimer's Disease

    phase 3 small molecule terminated

    1 trial

  10. Azeliragon 5mg

    vTv Therapeutics

    Alzheimer's Disease

    phase 3 small molecule terminated

    1 trial

  11. Azetukalner

    Xenon Pharmaceuticals

    Major Depressive Disorder

    phase 3 small molecule active

    3 trials

  12. Azetukalner

    Xenon Pharmaceuticals

    Bipolar Disorder

    phase 3 small molecule active

    1 trial

  13. Azetukalner

    Xenon Pharmaceuticals

    Bipolar Depression

    phase 3 small molecule active

    1 trial

  14. Azilsartan

    Takeda

    Pediatric Hypertension

    phase 3 small molecule completed

    2 trials

  15. Azilsartan Medoxomil

    Takeda

    Hypertension

    phase 3 small molecule completed

    7 trials

  16. Azilsartan Medoxomil and amlodipine

    Takeda

    Hypertension

    phase 3 small molecule completed

    1 trial

  17. Azilsartan medoxomil and chlorthalidone

    Takeda

    Safety

    phase 3 small molecule completed

    1 trial

  18. Azilsartan medoxomil and chlorthalidone

    Takeda

    Hypertension

    phase 3 small molecule completed

    2 trials

  19. Azilsartan medoxomil and chlorthalidone

    Takeda

    Essential Hypertension

    phase 3 small molecule completed

    4 trials

  20. Azilsartan medoxomil and olmesartan

    Takeda

    Hypertension

    phase 3 small molecule completed

    1 trial

  21. Azilsartan medoxomil with or without add-on chlorthalidone

    Takeda

    Hypertension

    phase 3 small molecule completed

    1 trial

  22. Azilsartan medoxomil/placebo

    Takeda

    Essential Hypertension

    phase 3 small molecule completed

    1 trial

  23. Azithromycin

    Cardiff Oncology

    Bronchopulmonary Dysplasia

    phase 3 small molecule terminated

    1 trial

  24. Azithromycin plus hydroxychloroquine

    Iterum Therapeutics plc

    Respiratory Tract Infection Viral

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources